Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 30, 2020
Evergreen Theragnostics celebrated the groundbreaking for its new manufacturing facility in Springfield, New Jersey.
read more
EVERSANA announced a partnership with Amazon Web Services (AWS) to accelerate generative artificial intelligence (AI) use cases across the life sciences industry.
read more
Eversana™ announced the appointment of Brigham Hyde, Ph.D. to President, Data & Analytics (D&A).
read more
Tuesday, January 27, 2026
Evestia Clinical announced the acquisition of ICRC-Weyer GmbH, a Berlin-based, long-established CRO and scientific consultancy. The acquisition strengthens Evestia Clinical's presence in Germany and Europe and further enhances the company's full-...
read more
Evestia Clinical, the new identity of EMAS Pharma, has launched as a provider of clinical research in oncology and rare diseases globally.
read more
Brigham and Women’s Innovation Hub (iHub) and Evidation Health have announced a collaboration to measure the real life impact of digital health solutions on clinical and economic outcomes.
read more
Evidation Health announced it has closed a $10 million funding round led by Sanofi-Genzyme BioVentures, the corporate venture capital arm of Sanofi.
read more
Evidera, a business unit of Pharmaceutical Product Development, LLC (PPD), has entered into an exclusive collaboration agreement with Clinical Study Support, Inc. (CSS), a subsidiary of Shin Nippon Biomedical Laboratories Ltd. (SNBL), extending both ...
read more
Evidera has entered into an agreement to acquire Medimix International, a technology company providing RWE insights and information to the pharmaceutical, diagnostic and medical device industries.
read more
evitria AG, a global antibody expression service provider located in Zurich, Switzerland, has entered into a non-exclusive bYlok® bispecific pairing technology license agreement with Lonza. Lonza’s bYlok® technology redefines IgG-like bispecific ...
read more
Tuesday, December 03, 2024
Sapio Sciences announced that evitria, a provider of antibody expression services, has selected Sapio’s Electronic Lab Notebook (ELN) and Sapio Report Builder to enhance its sample tracking, data capture, and reporting capabilities.
read more
Evoke Pharma announced that it has entered into an agreement with Rho, Inc., a regulatory consulting and contract research organization.
read more
EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced the appointment of Colin McCracken as Chief Executive Officer with immediate effect.
read more
EVONETIX, a synthetic biology company bringing semiconductor technology to DNA synthesis, today announced it has been granted a European patent covering its unique Binary Assembly method for gene synthesis.
read more
Friday, September 11, 2020
The companies will work together on the advancement and commercial scale-up of Evonetix’s proprietary MEMS-based silicon chips and accelerate the development of Evonetix’s first product, a DNA desktop writer.
read more